These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases]. Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913 [TBL] [Abstract][Full Text] [Related]
26. Successful treatment of solitary extracranial metastases from non-small cell lung cancer. Luketich JD; Martini N; Ginsberg RJ; Rigberg D; Burt ME Ann Thorac Surg; 1995 Dec; 60(6):1609-11. PubMed ID: 8787451 [TBL] [Abstract][Full Text] [Related]
27. [Analysis of neoplasm metastases to the bone marrow in patients with lung cancer]. Dziecioł J; Kemona A; Sulik M; Sobaniec-Lotowska M; Sulkowski S; Ostapiuk H; Pasztaleniec L; Deregowski K Pneumonol Pol; 1989 Apr; 57(4):235-9. PubMed ID: 2560829 [TBL] [Abstract][Full Text] [Related]
28. Bronchogenic cancer associated with head and neck tumors. Survival analysis of 194 patients. Massard G; Roeslin N; Jung GM; Dumont P; Wihlm JM; Morand G J Thorac Cardiovasc Surg; 1993 Aug; 106(2):218-27. PubMed ID: 8393506 [TBL] [Abstract][Full Text] [Related]
29. EGFR mutated non-small cell lung cancer patients: more prone to development of bone and brain metastases? Hendriks LE; Smit EF; Vosse BA; Mellema WW; Heideman DA; Bootsma GP; Westenend M; Pitz C; de Vries GJ; Houben R; Grünberg K; Bendek M; Speel EJ; Dingemans AM Lung Cancer; 2014 Apr; 84(1):86-91. PubMed ID: 24529684 [TBL] [Abstract][Full Text] [Related]
31. Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factors. Griffioen GH; Toguri D; Dahele M; Warner A; de Haan PF; Rodrigues GB; Slotman BJ; Yaremko BP; Senan S; Palma DA Lung Cancer; 2013 Oct; 82(1):95-102. PubMed ID: 23973202 [TBL] [Abstract][Full Text] [Related]
32. [Clinical diagnosis of brain metastases in bronchogenic carcinoma]. Schmid-Wermser I; Nagel GA; Schmid AH Schweiz Med Wochenschr; 1974 Mar; 104(13):464-8. PubMed ID: 4824417 [No Abstract] [Full Text] [Related]
33. [Should the extended evaluation of bronchial adenocarcinoma be different from that of non-small cell lung carcinoma?]. Milleron B; Guigay J; Rugeri L; Rosencher L; Terrioux P; Beerblock K; Akoun G Rev Pneumol Clin; 1992; 48(4):159-62. PubMed ID: 1338351 [TBL] [Abstract][Full Text] [Related]
34. Metastatic neoplasms of bone marrow. Clinical and morphological analysis of 71 cases. Zheng TL; Li DG; Zhang ZN; Cao JN; Li GX Chin Med J (Engl); 1985 May; 98(5):321-4. PubMed ID: 3926402 [No Abstract] [Full Text] [Related]
36. [Incidence of metastases and their distribution pattern in bronchial carcinoma. Autopsy findings during 5 decades (1935 to 1984)]. Notter M; Schwegler N Dtsch Med Wochenschr; 1989 Mar; 114(9):343-9. PubMed ID: 2537718 [No Abstract] [Full Text] [Related]
37. Osteolytic cortical destruction: an unusual pattern of skeletal metastases. Greenspan A; Norman A Skeletal Radiol; 1988; 17(6):402-6. PubMed ID: 3238438 [TBL] [Abstract][Full Text] [Related]
39. [Evaluation of the prognostic significance of refinement and stratification of distant metastasis status in 1016 cases of nasopharyngeal carcinoma]. Pan CC; Lu J; Chen P; Li X; Jin YD; Zhao M; Xia YF; Wu PH Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):595-9. PubMed ID: 24314217 [TBL] [Abstract][Full Text] [Related]
40. [How can metastatic bone involvement be assessed?]. Lumbroso J Rev Mal Respir; 1992; 9 Suppl 4():R281-5. PubMed ID: 1336874 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]